Lifeward (LFWD) Net Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 52.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.35% |
| Dec 31, 2025 | 26.79% |
| Sep 30, 2025 | 12.36% |
| Jun 30, 2025 | 45.63% |
| Mar 31, 2025 | 43.43% |
| Dec 31, 2024 | -11.27% |
| Sep 30, 2024 | -29.37% |
| Jun 30, 2024 | -21.02% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | -58.32% |
| Sep 30, 2023 | -103.26% |
| Jun 30, 2023 | -12.91% |
| Mar 31, 2023 | -169.89% |
| Dec 31, 2022 | -14.46% |
| Sep 30, 2022 | -8.91% |
| Jun 30, 2022 | -30.89% |
| Mar 31, 2022 | -103.97% |
| Dec 31, 2021 | -38.79% |
| Sep 30, 2021 | 107.92% |
| Jun 30, 2021 | -140.52% |
| Mar 31, 2021 | 116.70% |
| Dec 31, 2020 | 12.11% |
| Sep 30, 2020 | 47.32% |
| Jun 30, 2020 | -44.37% |
| Mar 31, 2020 | 27.08% |
| Dec 31, 2019 | -32.84% |
| Sep 30, 2019 | -4.11% |
| Jun 30, 2019 | 64.86% |
| Mar 31, 2019 | -29.48% |
| Dec 31, 2018 | 37.30% |
| Sep 30, 2018 | -38.34% |
| Jun 30, 2018 | -64.49% |
| Mar 31, 2018 | -5.75% |
| Dec 31, 2017 | 26.53% |
| Sep 30, 2017 | -27.18% |
| Jun 30, 2017 | -30.56% |
| Dec 31, 2016 | 85.29% |
| Sep 30, 2016 | -31.43% |